Promising Research In Coeliac Disease Detection

Imagine feeling exhausted and bloated for years, finally cutting out gluten, and then being told you have to eat bread and pasta for weeks just to confirm you have coeliac disease. This has been the grim reality of diagnosis—until now. Thanks to a new blood test developed by WEHI and Novoviah Pharmaceuticals, you may soon be able to get tested without making yourself sick.

The study, published in Gastroenterology, shows this test detects coeliac disease by finding specific gluten-sensitive T-cells in the blood, no gluten binge required.

What’s wrong with the current diagnosis system?

Current coeliac tests, including blood serology and biopsies, only work if you’re actively eating gluten. For many, this means enduring weeks of severe symptoms like vomiting, stomach pain, and chronic fatigue just to get a diagnosis.

It’s a cruel process that discourages people from getting tested, leaving up to 80% of coeliac cases worldwide undiagnosed. This new test would make diagnosis faster, safer, and less uncomfortable.

The Breakthrough Science: How It Works

Back in 2019, researchers made a key discovery: when someone with coeliac disease eats gluten, their immune system releases a signal called interleukin-2 (IL-2). This acts as a red alert in the bloodstream. The research team’s big question was whether they could trigger this signal without the patient eating gluten.

The answer was yes. In the latest study, researchers added gluten directly to blood samples from 181 volunteers in a test tube. If the blood sample showed a spike in IL-2, it meant the person had coeliac disease.

The results were impressive: the test had a 90% sensitivity and 97% specificity. This means it correctly identified 9 out of 10 people with coeliac disease and correctly ruled out coeliac in 97 out of 100 people without it. It worked even on people who had been gluten-free for years.

What Does This Mean for Coeliacs?

This new test is a game-changer. It not only detects coeliac disease but also gives an indication of how severe a person’s gluten reaction might be, all without them eating a single crumb.

While the technology isn’t yet in standard pathology labs, researchers are working to make it widely available. Ultimately, this test could end the need for the brutal “gluten challenge” and help diagnose thousands who would otherwise suffer in silence.

Your Coeliac Test Questions Answered

Q: What is the “gluten challenge” and what’s wrong with it?

A: The “gluten challenge” is the current standard for diagnosing coeliac disease in people who are already on a gluten-free diet. To be tested, you must reintroduce gluten into your diet for several weeks. This is necessary because current tests look for markers of an active immune reaction to gluten. For people with coeliac disease, this means intentionally making themselves sick again, enduring painful and debilitating symptoms like severe stomach cramps, bloating, vomiting, and chronic fatigue, just to prove they have the condition.

Q: How does this new test work without the “gluten challenge”?

A: The new test, developed by WEHI researchers, uses a unique method to trigger the body’s immune response in a lab setting, not in the patient. When a person with coeliac disease consumes gluten, their immune system releases a specific signal molecule called interleukin-2 (IL-2). Think of IL-2 as a “red alert” signal from the immune system’s T-cells. Instead of having the patient eat gluten, researchers simply add a tiny amount of gluten directly to a blood sample in a test tube. If the patient has coeliac disease, their T-cells will recognize the gluten and release IL-2, triggering that “red alert” and confirming the diagnosis.

Q: How accurate is this test? What do the terms “sensitivity” and “specificity” mean?

A: The test showed impressive accuracy in trials, with 90% sensitivity and 97% specificity.

Sensitivity measures how well the test correctly identifies people who do have the disease. A 90% sensitivity means that out of every 10 people with coeliac disease, the test correctly identified 9 of them.

Specificity measures how well the test correctly rules out the disease in people who don't have it. A 97% specificity means that out of every 100 people without coeliac disease, the test correctly identified 97 of them as negative.

These high numbers show the test is very reliable in both detecting coeliac disease and avoiding false positives.

Limitations of the Study

While this research is a promising breakthrough, it’s important to note its current limitations. The study was conducted at a single center with relatively small subgroups, so the results still need to be reproduced across different laboratories.

The test has not yet been assessed in pediatric populations or in patients who are on immunosuppressant medications. Additionally, it requires prospective validation to confirm its effectiveness in a broader patient population before it can be widely adopted.

Check out the original research here>